Perseis Therapeutics is developing therapies against Trefoil Factors (TFF-1 and TFF-3) and Growth Hormone for the treatment of breast and other cancers.

Perseis Therapeutics was established by Neuren Pharmaceuticals and the Breast Cancer Research Trust, and is based in Auckland, New Zealand.

Our Partners

• 
  Neuren Pharmaceuticals Limited is a biopharmaceutical company developing drugs for brain injury and neurodegeneration.
• 
  The Breast Cancer Research Trust is New Zealand's only not-for-profit organisation established solely to support research into breast cancer, with the goal to find a cure by 2018.